SCHEMBL4592841

SCHEMBL4592841

O=C(NC[C@@H]1CCN(C(=O)O)C1)c1ccc(Br)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
KDM4E B2RXH2 1/20 0.48
ESR1 P03372 1/20 0.48
ACKR3 P25106 2/20 0.47
F10 P00742 4/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
HPGD P15428 4/20 0.46
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HTT P42858 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4592548 0.86 F10 (0.52) ACKR3F10
SCHEMBL4592552 0.86 F10 (0.52) ACKR3F10
SCHEMBL4592230 0.83 ACKR3 (0.66) GAANPSR1RXFP1KDM4EACKR3
SCHEMBL3449148 0.83 ACKR3 (0.66) GAANPSR1RXFP1KDM4EACKR3
SCHEMBL3449150 0.83 ACKR3 (0.66) GAANPSR1RXFP1KDM4EACKR3
SCHEMBL4592619 0.83 ACKR3 (0.39) NPSR1ACKR3KMT2AMEN1
SCHEMBL4592144 0.81 ACKR3 (0.40) KDM4EACKR3NPC1
SCHEMBL14720130 0.80 CHIT1 (0.52) KDM4EALDH1A1KMT2AHDAC3HDAC4
SCHEMBL4592808 0.78 HPGD (0.52) NPSR1NPC1RAB9ATDP1HPGD
SCHEMBL4592805 0.78 HPGD (0.52) NPSR1NPC1RAB9ATDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1877404-A2 NOVEL CYCLIC AMINES F. Hoffmann-Roche AG (CH) 2008-01-16 EP disclosed
WO-2006114401-A2 NOVEL CYCLIC AMINES F. HOFFMANN-LA ROCHE AG (CH) 2006-11-02 WO disclosed